China Pharma Holdings (CPHI) Depreciation and Depletion (2016 - 2026)

China Pharma Holdings has reported Depreciation and Depletion for 11 years, with the latest figure at $155288.0 in Q1 2026.

• For the quarter ending Q1 2026, Depreciation and Depletion fell 9.51% year-over-year to $155288.0; the trailing twelve-month figure through Mar 2026 stood at $536794.0 (down 66.64% YoY), and the FY2025 full-year result was $652026.0, down 69.96% from the prior year.
• Depreciation and Depletion for Q1 2026 stood at $155288.0, up from $59927.0 in the prior quarter.
• The five-year high for Depreciation and Depletion was $673931.0 in Q1 2022, with the low at $59927.0 in Q4 2025.
• Historically, Depreciation and Depletion has averaged $467449.6 across 5 years, with a median of $630579.0 in 2023.
• Annual changes were most pronounced in 2024 — Depreciation and Depletion gained 1.92% — and 2025, when it slumped 80.53%.
• China Pharma Holdings' Depreciation and Depletion stood at $630781.0 in 2022, then gained by 0.44% to $633577.0 in 2023, then tumbled by 51.43% to $307741.0 in 2024, then sank by 80.53% to $59927.0 in 2025, then jumped by 159.13% to $155288.0 in 2026.
• The last three Depreciation and Depletion figures came in at $155288.0 (Q1 2026), $59927.0 (Q4 2025), and $158076.0 (Q3 2025), per Business Quant data.